Identification of a determining factor in luminal cancer cells

(Institute for Research in Biomedicine (IRB Barcelona)) Researchers at IRB Barcelona discover a new mechanism in estrogen receptor-positive breast cancer cells. The inhibition of CPEB2, a key factor in the estrogen signalling pathway, causes cancer cells to proliferate less and protects mice against luminal breast cancer.